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To the Editor: Coronary angiography necessitates administration of
iodinated contrast, which may precipitate an acute deterioration in
renal function (contrast-induced nephropathy [CIN]). Predisposing
factors include pre-existing chronic kidney disease and contrast
volume, which to some extent can be controlled. However, there has
been little investigation of the effect of contrast dose-response in
patients undergoing diagnostic coronary angiography with very low
doses (50 ml). The objective of this study was to determine the
incidence of CIN in a cohort of 185 patients with National Kidney
Foundation stages 3 to 5 chronic, nondialysis-dependent kidney
disease, undergoing diagnostic coronary angiography with iodinated
contrast (iodixanol) between November 2003 to November 2005, and
to investigate an association between contrast volume and CIN.
Patients were excluded if they had systolic blood pressure 90 mm
Hg, clinical shock, had no serum creatinine measurement within 1
week of angiography, or received intravenous contrast for other than
diagnostic angiography (e.g., ventriculography, graft angiography, or
intervention) or contrast either in the week preceding or following
angiography. Statistical analyses included analysis of variance, Student
t test, Pearson’s chi-square test, Kaplan-Meier analysis with log-rank
test, proportional hazard modeling (expressed as hazard ratio [HR]
and 95% confidence intervals [CIs]), and multivariate logistic regres-
sion with stepwise techniques. Statistics are presented as mean 
standard deviation, or median with interquartile range (IQR). Signif-
icance was inferred at p  0.05.
Sixty-eight percent of patients were men with a median age of
71 (IQR 60 to 78) years. Thirty-six percent had diabetes mellitus
and 40% had left ventricular systolic dysfunction (mean left
ventricular ejection fraction 50.1  15%). All patients had an
estimated glomerular filtration rate (eGFR) 60 ml/min. Median
serum creatinine was 2.1 mg/dl (IQR 1.8 to 2.5), and mean eGFR
was 31  10 ml/min/1.73 m2. Indications for coronary angiogra-
phy included an abnormal stress test (40%), acute coronary
syndrome (30%) before cardiac (valve) surgery (16%), and heart
failure (14%).
All patients underwent standard diagnostic coronary angiog-
raphy with a median contrast volume of 27 ml (IQR 20 to 50
ml), all with diagnostic quality images. The average procedure
and fluoroscopy times were 15.2  9 min and 4.2  3 min. Biplane
angiography was used in 114 patients (62%). All patients received
pre-procedure hydration (typically 0.45% NaCl 2 mg/kg/h at least
2 h before, during, and 2 h after angiography) and 97%
n-acetylcysteine. Significant obstructive coronary disease was
found in 64%, 58% of whom had triple-vessel disease.
The average time to peak creatinine was 3.8  3 days with
creatinine measurements performed an average of 4.3  3 times
per patient within 1 week of angiography. Contrast-induced
nephropathy defined as an absolute increase in serum creatinine
0.5 mg/dl within 7 days after the coronary angiogram occurred in
28 patients (15.1%). There were no baseline clinical factors in these
patients that distinguished them from the overall cohort.
The occurrence of CIN after diagnostic coronary angiography
was associated with an increased requirement for subsequent
dialysis with an incident rate within 1 year of angiography of 53.6%
(15 of 28) in those patients who developed CIN compared with
5.7% (9 of 157) in patients without CIN (p  0.0001). By
proportional hazard modeling, significant predictors of subsequent
need for dialysis were CIN (HR 4.2 [95% CI 2.7 to 6.5], p 
0.0001) and baseline eGFR (incremental 10 ml/min—HR 0.45
[95% CI 2.8 to 6.8], p  0.0002). Thirty-day mortality rates were
21.4% (6 of 28) in those patients who developed CIN compared
with 3.2% (5 of 157) in patients without CIN (p  0.0001).
Factors associated with 30-day mortality included the occurrence
of CIN (HR 2.74 [95% CI 1.5 to 5.1], p  0.002) and age
(incremental 10 years—HR 1.56 [95% CI 0.96 to 2.9], p  0.08).
The volume of contrast administered was directly associated
with the incidence of CIN. Volumes were higher in patients
developing CIN (45  18 ml) than those who did not (31  18
ml, p  0.0005). Those patients who received the lowest quartile of
contrast volume were 7-fold less likely to develop CIN compared with
those with the highest quartile of contrast volume (4.4% vs. 29.8%, p
 0.005) (Fig. 1). In multivariate analysis, the only significant factor
associated with CIN was the volume of contrast administered, with
each incremental 20 cc of contrast associated with an incremental
odds ratio of 2.12 (95% CI 1.4 to 3.4, p  0.0002).
Biplane angiography was used in 114 cases (62%) and was
associated with a significant reduction in contrast volume (25 13
ml vs. 47  20 ml, p  0.0001). The use of biplane angiography
was not associated with either longer procedural times (14.9  6
[biplane] vs. 15.6  10 [monoplane] min, p  0.6) or cumulative
fluoroscopy (4  2 [biplane] vs. 4.1  4 (monoplane) min, p 
0.4) times. Those patients who had imaging with biplane angiog-
raphy tended to have more diabetes (40.4% vs. 28.2%, p  0.09)
and worse renal function (eGFR 29  11 ml/min/1.73 m2 vs. 33
 9 ml/min/1.73 m2, p  0.005), both factors associated with an
increased risk for CIN (1). Despite this apparent higher risk, the
incidence of CIN among patients imaged with biplane angiogra-
phy was significantly lower at 7.8% (9 of 114) compared with
26.8% (19 of 71, p  0.0007) without the use of biplane. When
adjusted for baseline eGFR, the use of biplane angiography was
associated with a reduction in the rate of dialysis at 1 year after
angiography (p  0.02).
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The major finding of this study is that, as with procedures with
higher volumes of iodinated contrast, patients with moderate-
severe chronic kidney disease undergoing coronary angiography
have an increased, contrast-volume dependent risk of CIN. De-
spite an elevated risk (1–3) and a high incidence of CIN, ultra-low
volumes of contrast were associated with low rates of CIN. These
findings have important implications concerning the referral of a
patient with moderate-severe chronic kidney disease for diagnostic
coronary angiography. With biplane imaging, studies can be
performed with very low doses of iodinated contrast (without
prolonging procedural times or radiation exposure), suggesting this
technique may mitigate the risk of CIN in many patients at highest
risk.
Our findings of a very low incidence of CIN with ultra-low
doses of contrast are very encouraging, but some limitations of this
study need to be considered. Our study was not randomized.
While the major factor associated with CIN was contrast volume
and the major factor associated with contrast volume was the use
of biplane angiography, other factors need to be considered. The
use of the iso-osmolar nonionic contrast medium, and that the vast
majority received standard therapies of intravenous hydration and
N-acetylcysteine likely contributed to a reduction in CIN. While
patients had, on average, more than 4 serum creatinine measurements
in the week after angiography, we cannot exclude the possibility that
the peak measurement in some patients was not identified and hence
the overall incidence of CIN was underestimated.
The current findings support the use of ultra-low-dose iodin-
ated contrast facilitated by biplane angiography in patients at
increased risk for contrast nephropathy referred for coronary
angiography. Further studies will be required to assess the impact
of low-dose contrast on the incidence of contrast nephropathy.
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Letters to the Editor
Age Predicts Cancer Incidence
Better Than Statin-Induced
Low-Density Lipoprotein Level
I disagree with the data analysis in the recently published article
in the Journal suggesting an association between lower statin-
induced low-density lipoprotein (LDL) levels and increased
incidence of cancer (1). My analysis of the 8 larger and longer
trials (3 years and 1,000 patients) suggests a clear associa-
tion between increasing age and increased incidence of cancer
(Fig. 1) (r2  0.77, p  0.004, regression not corrected for
study size). Age is a known and biologically plausible risk factor
for cancer. Multivariate linear regression resulted in the follow-
ing model:
Yearly cancer incidence 
 1.103 0.012 · LDL on treatment 0.0614 · age
The overall model was significant with r2  0.83 and p  0.013.
The multivariate p value for the coefficient of age (p  0.055)
was nearly statistically significant and lower than the multivar-
Figure 1 Contrast-Induced Nephropathy
Dose-dependent association of volume of administered contrast with the inci-
dence of contrast-induced nephropathy (p  0.005 by analysis of variance).
Mean  standard deviation of contrast volume for each quartile shown in
parentheses.
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